Skip to main content

Advertisement

Log in

Diabetes Mellitus Affects Response to Neoadjuvant Chemoradiotherapy in the Management of Rectal Cancer

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Introduction

Although diabetic patients with rectal cancer have poorer outcomes than their nondiabetic counterparts, few studies have looked at diabetics’ response to therapy as an explanation for this disparity. This study compares the neoadjuvant chemoradiotherapy (CRT) response in diabetic and nondiabetic patients with locally advanced rectal cancers.

Methods

This is a single-institution, retrospective review of rectal cancer patients who received CRT followed by resection from 1995 to 2006. Pretreatment tumor–node–metastasis (TNM) staging was determined using endorectal ultrasound, computed tomography (CT) scan, and magnetic resonance imaging (MRI); post-treatment staging was determined by pathological review.

Results

110 patients were included; seventeen had diabetes and 93 were nondiabetics. Pretreatment staging was similar in both groups. Sixteen of the diabetics (94%) completed CRT compared to 92% (86/93) of the nondiabetics. Tumor downstaging rates were similar in the two groups (53% in diabetics, 52% in nondiabetics). Nondiabetic patients had a higher rate of nodal downstaging although not statistically significant (67% versus 27%, P = 0.80). While none of the diabetics patients achieved a pathologic complete response (pCR), 23% (21/93) of the nondiabetics did (P = 0.039). Local progression rates were higher in the diabetic group (24% versus 5%, P = 0.046).

Conclusion

Our study shows that neoadjuvant chemoradiotherapy in rectal cancer is less effective in diabetic patients than in nondiabetics. While minimal differences are found in the rate of downstaging, the rate of achieving a complete pathologic response was significantly higher in nondiabetic patients, and in fact was not seen in any of our diabetic patients. This may explain the poorer outcomes seen in diabetic patients with rectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cherrington A. Presidential Address: Diabetes: Past, Present, and Future. Diabetes Care 2006; 29:2158–64

    Article  PubMed  Google Scholar 

  2. Hu F, Manson J, Liu S, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999; 91:542–7

    Article  PubMed  CAS  Google Scholar 

  3. Will J, Galuska D, Vinicor F, et al. Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 1998; 147:816–25

    PubMed  CAS  Google Scholar 

  4. Coughlin S, Calle E, Teras L, et al. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 2004; 159:1160–7

    Article  PubMed  Google Scholar 

  5. Meyerhardt J, Catalano P, Haller D, et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 2003; 21:433–40

    Article  PubMed  Google Scholar 

  6. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. NEJM 2004; 351:1731–40

    Article  PubMed  CAS  Google Scholar 

  7. Jones R, Smith I. Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response. Lancet Oncol 2006; 7:869–74

    Article  PubMed  CAS  Google Scholar 

  8. Reynolds J, Muldoon C, Hollywood D, et al. Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg 2007; 245:707–16

    Article  PubMed  Google Scholar 

  9. Valentini V, Coco C, Picciocchi A, et al. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 2002; 53:664–74

    PubMed  Google Scholar 

  10. Garcia-Aguilar J, Hernandez de Anda E, Sirivongs P, et al. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by a mesorectal excision. Dis Colon Rectum 2003; 46:298–304

    Article  PubMed  Google Scholar 

  11. Theodoropoulos G, Wise W, Padmanabhan A, et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 2002; 45:895–903

    Article  PubMed  Google Scholar 

  12. Chan A, Wong A, Jenken D, et al. Post treatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2005; 61:665–77

    PubMed  Google Scholar 

  13. Stipa F, Chessin D, Shia J, et al. A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography. Ann Surg Oncol 2006; 13:1047–53

    Article  PubMed  Google Scholar 

  14. Tran T, Medline A, Bruce W. Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 1996; 5:1013–15

    PubMed  CAS  Google Scholar 

  15. Wu Y, Yakar S, Zhao L, et al. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res 2002; 62

  16. Komninou D, Ayonote A, Richie J, et al. Insulin resistance and its contribution to colon carcinogenesis. Exper Biol Med 2003; 228:396–405

    CAS  Google Scholar 

  17. Rechler M. Growth inhibition by insulin-like growth factor (IGF) binding protein-3-what’s IGF got to do with it? Endocrinology 1997; 138:2645–7

    Article  PubMed  CAS  Google Scholar 

  18. Schoen R, Tangen C, Kuller L, et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 1999; 91:1147–54

    Article  PubMed  CAS  Google Scholar 

  19. Kaaks R, Toniolo C, Akhmedkhanov A, et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000; 92:1592–600

    Article  PubMed  CAS  Google Scholar 

  20. McKeown-Essen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 1994; 3:687–95

    Google Scholar 

  21. Keku T, Lund P, Galanko J, et al. Insulin resistance, apoptosis, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2005; 14:2076–81

    Article  PubMed  CAS  Google Scholar 

  22. Jordan B, Gregoire V, Demeure R, et al. Insulin increases the sensitivity of tumors to irradiation: involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption. Cancer Res 2002; 62:3555–61

    PubMed  CAS  Google Scholar 

  23. Vignali A, Fazio V, Lavery I, et al. Factors associated with the occurrence of leaks in stapled rectal anastomoses: a review of 1,014 patients. J Am Coll Surg 1997; 185:105–13

    PubMed  CAS  Google Scholar 

  24. Epanomeritakis E, Koutsoumbi P, Tsiaoussis I, et al. Impairment of anorectal function in diabetes mellitus parallels duration of disease. Dis Colon Rectum 1999; 42:1394–400

    Article  PubMed  CAS  Google Scholar 

  25. Roeske J, Mundt A, Hapern H, et al. Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis. Int J Radiat Oncol Biol Phys 1997; 37:351–8

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. O. Meyers MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caudle, A.S., Kim, H.J., Tepper, J.E. et al. Diabetes Mellitus Affects Response to Neoadjuvant Chemoradiotherapy in the Management of Rectal Cancer. Ann Surg Oncol 15, 1931–1936 (2008). https://doi.org/10.1245/s10434-008-9873-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-008-9873-6

Keywords

Navigation